{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:34:48Z","timestamp":1790904888440,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007225","name":"Universidade de Lisboa Instituto Superior T\u00e9cnico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007225","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ccell.2022.12.009","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T11:45:00Z","timestamp":1674128700000},"page":"288-303.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Base editing screens map mutations affecting interferon-\u03b3 signaling in cancer"],"prefix":"10.1016","volume":"41","author":[{"given":"Matthew A.","family":"Coelho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena E.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Karakoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shriram","family":"Bhosle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Picco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Burgold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara M.","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Veninga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Consonni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansu","family":"Din\u00e7er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara F.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syd","family":"Barthorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Rein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Marioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile E.","family":"Voest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2618-4237","authenticated-orcid":false,"given":"Mathew J.","family":"Garnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2022.12.009_bib1","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1073\/pnas.1401180111","article-title":"Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition","volume":"111","author":"Lupardus","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2022.12.009_bib2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"16","author":"Schwartz","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ccell.2022.12.009_bib3","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1073\/pnas.95.13.7556","article-title":"Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice","volume":"95","author":"Kaplan","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2022.12.009_bib4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.009_bib5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2022.12.009_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","article-title":"Primary resistance to PD-1 blockade mediated by JAK1\/2 mutations","volume":"7","author":"Shin","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2022.12.009_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","article-title":"Loss of IFN-gamma pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy","volume":"167","author":"Gao","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.009_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15440","article-title":"Acquired IFNgamma resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions","volume":"8","author":"Sucker","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2022.12.009_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.009_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature23477","article-title":"Identification of essential genes for cancer immunotherapy","volume":"548","author":"Patel","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.009_bib11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41586-022-04585-5","article-title":"CAR T\u00a0cell killing requires the IFNgammaR pathway in solid but not liquid tumours","volume":"604","author":"Larson","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.009_bib12","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations in cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2022.12.009_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.009_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41388-019-0968-2","article-title":"A CRISPR-based base-editing screen for the functional assessment of BRCA1 variants","volume":"39","author":"Kweon","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2022.12.009_bib15","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1038\/s41467-020-15796-7","article-title":"Perturbing proteomes at single residue resolution using base editing","volume":"11","author":"Despr\u00e9s","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2022.12.009_bib16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s42003-020-0888-2","article-title":"Single-cell analysis of a mutant library generated using CRISPR-guided deaminase in human melanoma cells","volume":"3","author":"Jun","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ccell.2022.12.009_bib17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.cell.2021.01.041","article-title":"Functional interrogation of DNA damage response variants with base editing screens","volume":"184","author":"Cuella-Martin","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.009_bib18","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2021.01.012","article-title":"Massively parallel assessment of human variants with base editor screens","volume":"184","author":"Hanna","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.009_bib19","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41587-021-01172-3","article-title":"Base editing sensor libraries for high-throughput engineering and functional analysis of cancer-associated single nucleotide variants","volume":"40","author":"S\u00e1nchez-Rivera","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2022.12.009_bib20","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41587-022-01276-4","article-title":"High-throughput functional evaluation of human cancer-associated mutations using base editors","volume":"40","author":"Kim","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2022.12.009_bib21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.009_bib22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2217T to G\u2217C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.009_bib23","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2022.12.009_bib24","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.immuni.2017.11.016","article-title":"Oncogenic RAS signaling promotes tumor immunoresistance by stabilizing PD-L1 mRNA","volume":"47","author":"Coelho","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.ccell.2022.12.009_bib25","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1158\/2159-8290.CD-19-1416","article-title":"Inactivation of Fbxw7 impairs dsRNA sensing and confers resistance to PD-1 blockade","volume":"10","author":"Gstalder","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2022.12.009_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s43586-021-00093-4","article-title":"High-content CRISPR screening","volume":"2","author":"Bock","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.ccell.2022.12.009_bib27","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.cell.2018.10.024","article-title":"Genome-wide CRISPR screens in primary human T\u00a0cells reveal key regulators of immune function","volume":"175","author":"Shifrut","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.009_bib28","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cell.2019.06.014","article-title":"Augmenting immunotherapy impact by lowering tumor TNF cytotoxicity threshold","volume":"178","author":"Vredevoogd","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.009_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2746-2","article-title":"Functional genomic landscape of cancer-intrinsic evasion of killing by T\u00a0cells","volume":"586","author":"Lawson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.009_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature23270","article-title":"In\u00a0vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target","volume":"547","author":"Manguso","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.009_bib31","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cell.2019.07.044","article-title":"Systematic immunotherapy target discovery using genome-scale in\u00a0vivo CRISPR screens in CD8 T\u00a0cells","volume":"178","author":"Dong","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.009_bib32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.aao1710","article-title":"A major chromatin regulator determines resistance of tumor cells to T\u00a0cell-mediated killing","volume":"359","author":"Pan","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ccell.2022.12.009_bib33","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2022.12.009_bib34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41586-019-1103-9","article-title":"Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens","volume":"568","author":"Behan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.009_bib35","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cell.2015.11.015","article-title":"High-Resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities","volume":"163","author":"Hart","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.009_bib36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12859-016-1015-8","article-title":"BAGEL: a computational framework for identifying essential genes from pooled library screens","volume":"17","author":"Hart","year":"2016","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ccell.2022.12.009_bib37","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","article-title":"MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens","volume":"15","author":"Li","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2022.12.009_bib38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13073-019-0665-3","article-title":"Identifying chemogenetic interactions from CRISPR screens with drugZ","volume":"11","author":"Colic","year":"2019","journal-title":"Genome Med."},{"key":"10.1016\/j.ccell.2022.12.009_bib39","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2022.12.009_bib40","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1074\/jbc.M115.664995","article-title":"Interferon gamma (IFNgamma) signaling via mechanistic target of rapamycin complex 2 (mTORC2) and regulatory effects in the generation of type II interferon biological responses","volume":"291","author":"Kroczynska","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ccell.2022.12.009_bib41","doi-asserted-by":"crossref","first-page":"D923","DOI":"10.1093\/nar\/gky872","article-title":"Cell Model Passports-a hub for clinical, genetic and functional datasets of preclinical cancer models","volume":"47","author":"van der Meer","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2022.12.009_bib42","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41467-018-04013-1","article-title":"The molecular basis of JAK\/STAT inhibition by SOCS1","volume":"9","author":"Liau","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2022.12.009_bib43","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1038\/s41467-022-29442-x","article-title":"Ubiquitin ligase STUB1 destabilizes IFNgamma-receptor complex to suppress tumor IFNgamma signaling","volume":"13","author":"Apriamashvili","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2022.12.009_bib44","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12915-018-0617-1","article-title":"BE-FLARE: a fluorescent reporter of base editing activity reveals editing characteristics of APOBEC3A and APOBEC3B","volume":"16","author":"Coelho","year":"2018","journal-title":"BMC Biol."},{"key":"10.1016\/j.ccell.2022.12.009_bib45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2022.12.009_bib46","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2022.12.009_bib47","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1126\/science.aas9129","article-title":"Engineered CRISPR-Cas9 nuclease with expanded targeting space","volume":"361","author":"Nishimasu","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ccell.2022.12.009_bib48","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nbt.4172","article-title":"Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction","volume":"36","author":"Koblan","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2022.12.009_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aao4774","article-title":"Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity","volume":"3","author":"Komor","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ccell.2022.12.009_bib50","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41587-020-0414-6","article-title":"Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors","volume":"38","author":"Doman","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2022.12.009_bib51","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nbt.3803","article-title":"Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions","volume":"35","author":"Kim","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2022.12.009_bib52","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","article-title":"Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity","volume":"38","author":"Richter","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2022.12.009_bib53","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20199380","article-title":"Using deep mutational scanning to benchmark variant effect predictors and identify disease mutations","volume":"16","author":"Livesey","year":"2020","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.ccell.2022.12.009_bib54","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2022.12.009_bib55","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s41588-018-0200-2","article-title":"Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors","volume":"50","author":"Miao","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2022.12.009_bib56","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ccell.2022.12.009_bib57","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ccell.2022.12.009_bib58","doi-asserted-by":"crossref","first-page":"eaah3560","DOI":"10.1126\/scitranslmed.aah3560","article-title":"Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance","volume":"9","author":"Roh","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ccell.2022.12.009_bib59","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2022.12.009_bib60","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenvironment evolution during immunotherapy with nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.009_bib61","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141, 456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.009_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41596-019-0232-9","article-title":"Tumor organoid-T-cell coculture systems","volume":"15","author":"Cattaneo","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ccell.2022.12.009_bib63","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","article-title":"Generation of tumor-reactive T\u00a0cells by Co-culture of peripheral Blood lymphocytes and tumor organoids","volume":"174","author":"Dijkstra","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.009_bib64","article-title":"Distinct mechanisms of mismatch repair deficiency delineate two modes of response to PD-1 immunotherapy in endometrial carcinoma","author":"Chow","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2022.12.009_bib65","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2021.01.002","article-title":"Meta-analysis of tumor- and T\u00a0cell-intrinsic mechanisms of sensitization to checkpoint inhibition","volume":"184","author":"Litchfield","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.009_bib66","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1158\/2159-8290.CD-17-0833","article-title":"Ex\u00a0vivo profiling of PD-1 blockade using organotypic tumor spheroids","volume":"8","author":"Jenkins","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2022.12.009_bib67","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/2159-8290.CD-18-0099","article-title":"STK11\/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma","volume":"8","author":"Skoulidis","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2022.12.009_bib68","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ccell.2022.12.009_bib69","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2022.12.009_bib70","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41588-019-0431-x","article-title":"Determining protein structures using deep mutagenesis","volume":"51","author":"Schmiedel","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2022.12.009_bib71","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-018-0461-z","article-title":"Accurate classification of BRCA1 variants with saturation genome editing","volume":"562","author":"Findlay","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.009_bib72","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41586-021-03771-1","article-title":"In silico saturation mutagenesis of cancer genes","volume":"596","author":"Mui\u00f1os","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.009_bib73","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2022.12.009_bib74","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuron.2019.07.014","article-title":"CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons","volume":"104","author":"Tian","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.ccell.2022.12.009_bib75","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1038\/s41467-021-26211-0","article-title":"Human cell based directed evolution of adenine base editors with improved efficiency","volume":"12","author":"Fu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2022.12.009_bib76","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1093\/bioinformatics\/btv308","article-title":"WGE: a CRISPR database for genome engineering","volume":"31","author":"Hodgkins","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2022.12.009_bib77","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.molcel.2017.08.008","article-title":"CRISPR-mediated base editing enables efficient disruption of eukaryotic genes through induction of STOP codons","volume":"67","author":"Billon","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccell.2022.12.009_bib78","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nbt.2800","article-title":"Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library","volume":"32","author":"Koike-Yusa","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2022.12.009_bib79","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1038\/s41467-020-17952-5","article-title":"CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs","volume":"11","author":"Coelho","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ccell.2022.12.009_bib80","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13059-019-1628-0","article-title":"Guide RNAs with embedded barcodes boost CRISPR-pooled screens","volume":"20","author":"Zhu","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2022.12.009_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/cpbi.20","article-title":"cgpCaVEManWrapper: simple execution of CaVEMan in order to detect somatic single nucleotide variants in NGS data","volume":"56","author":"Jones","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.ccell.2022.12.009_bib82","doi-asserted-by":"crossref","first-page":"giab008","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"GigaScience"},{"key":"10.1016\/j.ccell.2022.12.009_bib83","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ccell.2017.07.005","article-title":"Genomic evolution of breast cancer metastasis and relapse","volume":"32","author":"Yates","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2022.12.009_bib84","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.ccell.2022.12.009_bib85","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ccell.2022.12.009_bib86","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.celrep.2016.09.079","article-title":"A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia","volume":"17","author":"Tzelepis","year":"2016","journal-title":"Cell Rep."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610822005955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610822005955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:09:06Z","timestamp":1761523746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610822005955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1535610822005955"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2022.12.009","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Base editing screens map mutations affecting interferon-\u03b3 signaling in cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2022.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}